Table 4. Vaccination coveragea of refugee children at 25 mainland camps, Greece, April 2018 (n=3,786).
Disease | Vaccine doses | Camp size (1–99 children) |
Camp size (≥ 100 children) |
p valueb |
---|---|---|---|---|
Mean (± SD) | Mean (± SD) | |||
MMR | No dose | 39.9 (± 32.28) | 16.9 (± 11.43) | 0.016 |
At least one dose | 60.1 (± 32.28) | 83.06 (± 11.43) | ||
DTPc | No dose | 69.2 (± 13.15) | 56.2 (± 19.85) | 0.094 |
At least one dose | 30.8 (± 13.15) | 43.8 (± 19.85) | ||
Poliomyelitis | No dose | 69.2 (± 13.15) | 56.0 (± 20.04) | 0.090 |
At least one dose | 30.8 (± 13.15) | 44.0 (± 20.04) | ||
Pneumococcal disease | No dose | 56.1 (± 29.40) | 56.4 (± 19.67) | 0.977 |
At least one dose | 43.9 (± 29.40) | 43.6 (± 19.67) | ||
Haemophilus influenzae type b | No dose | 69.7 (± 13.00) | 56.2 (± 19.84) | 0.081 |
At least one dose | 30.3 (± 13.00) | 43.8 (± 19.84) | ||
Hepatitis B | No dose | 68.5 (± 13.66) | 52.8 (± 22.75) | 0.073 |
At least one dose | 31.5 (± 13.66) | 47.2 (± 22.75) |
DTP: Diphtheria-tetanus-pertussis; MMR: measles-mumps-rubella; SD: standard deviation.
a Vaccination coverage against MMR for children 1–14 years of age (n = 3,501) and vaccination coverage against diphtheria-tetanus-pertussis, poliomyelitis, pneumococcal disease, Haemophilus influenzae type b and hepatitis B for children 0–4 years of age (n = 1,509), by camp size (1–99 children and ≥ 100).
b Student's t-test p-value.